Intermittent high glucose enhances proliferation of vascular smooth muscle cells by upregulating osteopontin

Molecular and Cellular Endocrinology

Volumn 313, Issue 1-2, 2009, Pages 64-69

  Sun, Jiazhong ^a   Xu, Yancheng ^a   Dai, Zhe ^a   Sun, Yanlei ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Atherosclerosis; Intermittent high glucose; Osteopontin; VSMCs

Indexed keywords

BETA3 INTEGRIN RECEPTOR; BETA5 INTEGRIN; BETA5 INTEGRIN RECEPTOR; GELATINASE A; GLUCOSE; INTEGRIN RECEPTOR; MESSENGER RNA; NEUTRALIZING ANTIBODY; OSTEOPONTIN; THYMIDINE; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; AORTA; ARTICLE; ATHEROSCLEROSIS; CELL PROLIFERATION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; GENE EXPRESSION; GLYCEMIC CONTROL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; GLUCOSE; HUMANS; HYPERGLYCEMIA; MALE; MATRIX METALLOPROTEINASE 2; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OSTEOPONTIN; RATS; RATS, WISTAR;

EID: 70349484248     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2009.08.019     Document Type: Article

References (40)

1. Alipui C., Ramos K., and Tenner T.E. Alterations of rabbit aortic smooth muscle cell proliferation in diabetes mellitus. Cardiovasc. Res. 27 (1993) 1229-1232
2. Ambalavanan N., Nicola T., and Li P. Role of matrix metalloproteinase-2 in newborn mouse lungs under hypoxic conditions. Pediatr. Res. 63 (2008) 26-32
3. Bastyr E.J., Stuart C.A., Brodows R.G., Schwartz S., Graf C.J., Zagar A., and Robertson K.E. Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c: IOEZStudy Group. Diabetes Care 23 (2000) 1236-1241
4. Beckman J.A., Creager M.A., and Libby P. Diabetes and atherosclerosis. JAMA 287 (2002) 2570-2581
5. Ceriello A. The emerging role of post-prandial hyperglycaemic spikes in the pathogenesis of diabetic complications. Diabet. Med. 15 (1998) 188-193
6. Ceriello A. Impaired glucose tolerance and cardiovascular disease: the possible role of post-prandial hyperglycemia. Am. Heart. J. 147 (2004) 803-807
7. Ceriello A., Esposito K., Piconi L., and Ihnat M.A. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 57 (2008) 1349-1354
8. Cheng S.L., Lai C., Fausto A., Chellaiah M., Feng X., McHugh K., Tietelbaum S., Civitelli R., Hruska K., Ross P., and Avioli L.V. Regulation of alphaVbeta3 and alphaVbeta5 integrins by dexamethasone in normal human osteoblastic cells. J. Cell Biochem. 77 (2000) 265-276
9. Delbosc S., Glorian M., and Le Port A.S. The benefit of docosahexanoic acid on the migration of vascular smooth muscle cells is partially dependent on Notch regulation of MMP-2/-9. Am. J. Pathol. 172 (2008) 1430-1440
10. Fischer J.W., Tschope C., Reinecke A., Giacehelli C.M., and Unger T. Upregulation of osteopontin expression in renal cortex of streptozotocin-induced diabetic rat is mediated by bradykinin. Diabetes 47 (1998) 1512-1518
11. Giachelli C.M., Bee N., Almeida M., Denhardt D.T., Alpers C.E., and Schwartz S.M. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J. Clin. Invest. 92 (1993) 1686-1696
12. Ikeda T., Shirasawa T., Esaki Y., Toshiki S., and Hirokawa K. Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta. J. Clin. Invest. 92 (1993) 2814-2820
13. Isoda K., Kamezawa Y., Ayaori M., Kusuhara M., Tada N., and Ohsuzu F. Osteopontin transgenic mice fed a high-cholesterol diet develop early fatty-streak lesions. Circulation 107 (2003) 679-681
14. Jones S.C., Saunders H.J., and Qi W. Intermittent high glucose enhances cell growth and collagen synthesis in cultured human tubulointerstitial cells. Diabetologia 42 (1999) 1113-1119
15. Kawamura H., Yokote K., Asaumi S., Kobayashi K., Fujimoto M., Maezawa Y., Saito Y., and Mori S. High glucose-induced upregulation of osteopontin is mediated via Rho/Rho kinase pathway in cultured rat aortic smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 24 2 (2004) 276-281
16. Kawano H., Cody R.J., Graf K., Goetze S., Kawano Y., Schnee J., Law R.E., and Hsueh W.A. Angiotensin II enhances integrin and a-actinin expression in adult rat cardiac fibroblasts. Hypertension 35 (2000) 273-279
17. Krolewski A.S., Warram J.H., Valsania P., Martin B.C., and Laffel L.M. Evolving natural history of coronary artery disease in diabetes mellitus. Am. J. Med. 90 (1991) 56S-61S
18. Kwon H.M., Hong B.K., Kang T.S., Kwon K., Kim H.K., and Jang Y. Expression of osteopontin in calcified coronary atherosclerotic plaques. J. Korean Med. Sci. 15 (2000) 483-493
19. Lee E.S., Bauer G.E., Caldwell M.P., and Santilli S.M. Association of artery wall hypoxia and cellular proliferation at a vascular anastomosis. J. Surg. Res. 91 (2000) 32-37
20. Li J.J., Han M., and Wen J.K. Osteopontin stimulates vascular smooth muscle cell migration by inducing FAK phosphorylation and ILK dephosphorylation. Biochem. Biophys. Res. Commun. 356 (2007) 13-19
21. Liaw L., Lombardi D.M., Almeida M.M., Schwartz S.M., deBlois D., and Giachelli C.M. Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudation. Arterioscler. Thromb. Vasc. Biol. l17 (1997) 188-193
22. Lo I.C., Shih J.M., and Jiang M.J. Reactive oxygen species and ERK 1/2 mediate monocyte chemotactic protein-1-stimulated smooth muscle cell migration. J. Biomed. Sci. 12 2 (2005) 377-388
23. Massi-Benedetti M., and Federici M.O. Cardiovascular risk factors in type 2 diabetes: the role of hyperglycaemia. Exp. Clin. Endocrinol. Diabetes 107 (1999) S120-123
24. Matsui Y., Rittling S.R., Okamoto H., Inobe M., Jia N., and Shimizu T. Osteopontin deficiency attenuates atherosclerosis in female apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. l23 (2003) 1029-1034
25. Monnier L., Mas E., Ginet C., Michel F., Villon L., Cristol J.P., and Colette C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295 (2006) 1681-1687
26. Natarajan R., Gonzales N., Xu L., and Nadler J.L. Vascular smooth muscle cells exhibit increased growth in response to elevated glucose. Biochem. Biophys. Res. Commun. 187 (1992) 552-560
27. Oikawa S., Hayasaka K., Hashizume E., Kotake H., Midorikawa H., Sekikawa A., Kikuchi A., and Toyota T. Human arterial smooth muscle proliferation in diabetes. Diabetes 45 (1996) S114-S116
28. Ruderman N.B., and Haudenschild C. Diabetes as an atherogenic factor. Prog. Cardiovasc. Dis. 26 (1984) 373-412
29. Sahai A., Mei C., Pattison T., and Tannen R.L. Chronic hypoxia induces proliferation of cultured rat mesangial cells: role of calcium and protein kinase C. Am. J. Physiol. 273 (1997) F954-F960
30. Shanahan C.M., Cary N.R., Metcalfe J.C., and Weissberg P.L. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J. Clin. Invest. 93 (1994) 2393-2402
31. Singleton J.R., Smith A.G., Russell J.W., and Feldman E.L. Microvascular complications of impaired glucose tolerance. Diabetes 52 (2003) 2867-2873
32. Sodhi C.P., Batlle D., and Sahai A. Osteopontin mediates hypoxia-induced proliferation of cultured mesangial cells: role of PKC and p38MAPkinase. Kidney Int. 58 (2000) 691-700
33. Sodhi C.P., Phadke S.A., Batlle D., and Sahai A. Hypoxia stimulates osteopontin expression and proliferation of cultured vascular smooth muscle cells: potentiation by high glucose. Diabetes 50 6 (2001) 1482-1490
34. Solomatina M.A., Plekhanova O.S., and Men'shikova M.Y. Urokinase increases the content and activity of matrix metalloproteinases 2 and 9 during in vivo constrictive arterial remodelling. Bull. Exp. Biol. Med. 139 (2005) 283-286
35. Srivastava A.K. High glucose-induced activation of protein kinase signaling pathways in vascular smooth muscle cells: a potential role in the pathogenesis of vascular dysfunction in diabetes. Int. J. Mol. Med. 9 (2002) 85-89
36. Stamler J., Vaccaro O., Neaton J.D., and Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16 (1993) 434-444
37. Takemoto M., Yokote K., Nishimura M., Shigematsu T., Hasegawa T., Kon S., Uede T., Matsumoto T., Saito Y., and Mori S. Enhanced expression of osteopontin in human diabetic artery and analysis of its functional role in accelerated atherogenesis. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 624-628
38. Takemoto M., Yokote K., Yamazaki M., Ridall A.L., Butler W.T., Matsumoto T., Tamura K., Saito Y., and Mori S. Enhanced expression of osteopontin by high glucose in cultured rat aortic smooth muscle cells. Biochem. Biophys. Res. Commun. 258 (1999) 722-726
39. Takeuchi A., Throckmorton D.C., and Brogden A.P. Periodic high extracellular glucose enhances production of collagens III and IV by mesangial cells. Am. J. Physiol. 268 (1995) F13-F19
40. Towler D.A., Bidder M., Latifi T., Coleman T., and Semenkovich C.F. Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice. J. Biol. Chem. 273 (1998) 30427-30434